SCHEMBL4013151

SCHEMBL4013151

COc1ccc(C2=CC(Cl)=CC[CH]2)c(-c2ccc(Cl)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
NPSR1 Q6W5P4 3/20 0.41
ALOX12 P18054 3/20 0.41
MAPT P10636 2/20 0.41
ALOX15 P16050 2/20 0.41
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
MDM2 Q00987 2/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047619 0.76 CYP1A1 (0.40) KMT2AMAPTCYP1A2CYP2D6CYP2C9
SCHEMBL4149059 0.73 CYP1A2 (0.34) CYP1A2LMNA
SCHEMBL6047605 0.72 CYP1A1 (0.44) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL6047642 0.69 MAOB (0.42) MEN1KMT2ANPSR1MAPTNPC1
SCHEMBL14301863 0.69 MEN1 (0.52) MEN1KMT2ANPSR1ALOX12MAPT
SCHEMBL18557563 0.69 MEN1 (0.49) MEN1KMT2ANPSR1ALOX12MAPT
SCHEMBL10801732 0.69 ABL1 (0.50) MEN1KMT2ANPSR1ALOX12MAPT
SCHEMBL6047656 0.69 HCRTR1 (0.36) NPC1RAB9A
SCHEMBL6047648 0.68 NAAA (0.42) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL5250908 0.68 CYP11B1 (0.50) MEN1KMT2ANPSR1ALOX12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed
EP-1781617-A4 ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARMACEUTICA NV (BE) 2009-06-24 EP disclosed
EP-1781617-A2 ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-09 EP disclosed
EP-1641762-A2 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-04-05 EP disclosed
WO-2006004742-A2 α, β-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARAMCEUTICA N.V. (BE) 2006-01-12 WO disclosed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP disclosed
WO-2005005393-A2 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-01-20 WO disclosed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO disclosed